title: [Oral contraceptives and thrombocytopenic thrombotic purpura].
authors.forename: A
authors.initials: A
authors.lastname: López Izquierdo
authors.forename: J M
authors.initials: JM
authors.lastname: Calvo-Villas
authors.forename: M
authors.initials: M
authors.lastname: Ramírez-Sánchez
authors.forename: F
authors.initials: F
authors.lastname: Sicilia Guillén
mesh_terms: D000328:Adult; D001803:Blood Transfusion; D003277:Contraceptives, Oral, Combined / Q000009:adverse effects*; D003278:Contraceptives, Oral, Hormonal / Q000009:adverse effects*; D003534:Cyproterone / Q000009:adverse effects*; D004176:Dipyridamole / Q000627:therapeutic use; D004958:Estradiol / Q000009:adverse effects*; D005260:Female; D006801:Humans; D010949:Plasma; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D011241:Prednisone / Q000627:therapeutic use; D011697:Purpura, Thrombotic Thrombocytopenic / Q000139:chemically induced* / Q000628:therapy; D014750:Vincristine / Q000627:therapeutic use
chemical_list: D003277:Contraceptives, Oral, Combined; D003278:Contraceptives, Oral, Hormonal; D010975:Platelet Aggregation Inhibitors; D004958:Estradiol; D014750:Vincristine; D004176:Dipyridamole; D003534:Cyproterone; D011241:Prednisone